T1	Premise 1103 1294	The mean total costs per patient in the UAE group were significantly lower than those in the hysterectomy group ($11,626 vs $18,563; mean difference, -$6,936 [-37%], 95% CI: -$9,548, $4,281).
T2	Claim 1909 2029	From a societal economic perspective, UAE is the superior treatment strategy in women with symptomatic uterine fibroids.
T3	Premise 1837 1908	The 24-month cumulative cost of UAE is lower than that of hysterectomy.
T4	Premise 1589 1753	The costs related to absence from work differed significantly between the treatment strategies in favor of UAE (mean difference, -$5,453; 95% CI: -$7,718, -$3,107).
T5	Premise 1295 1450	The direct medical in-hospital costs were significantly lower in the UAE group: $6,688 vs $8,313 (mean difference, -$1,624 [-20%], 95% CI: -$2,605, -$586).
T6	Premise 1451 1588	Direct medical out-of-hospital and direct nonmedical costs were low in both groups (mean cost difference, $156 in favor of hysterectomy).
R1	Support Arg1:T3 Arg2:T2	
R2	Support Arg1:T4 Arg2:T2	
R3	Support Arg1:T6 Arg2:T2	
R4	Support Arg1:T5 Arg2:T2	
R5	Support Arg1:T1 Arg2:T2	
